ArticleJAMA network open2022

Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy.

Kerstin Hellwig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.